Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? (Q50894485)

24 March 2018

title

Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? (English)

1 reference

24 March 2018

author

Peter J. Schwartz

8

1 reference

24 March 2018

author name string

Pratt CM

1

1 reference

24 March 2018

Camm AJ

2

1 reference

24 March 2018

Cooper W

3

1 reference

24 March 2018

Friedman PL

4

1 reference

24 March 2018

MacNeil DJ

5

1 reference

24 March 2018

Moulton KM

6

1 reference

24 March 2018

Pitt B

7

1 reference

24 March 2018

Veltri EP

9

1 reference

24 March 2018

Waldo AL

10

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

24 March 2018

American Journal of Cardiology

published in

1 reference

24 March 2018

volume

81

1 reference

24 March 2018

issue

7

1 reference

24 March 2018

page(s)

869-876

1 reference

24 March 2018

Ventricular premature complexes and sudden death after myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Clinical classification of cardiac deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

K+ Channel Blockade in the Prevention of Ventricular Fibrillation in Dogs with Acute Ischemia and Enhanced Sympathetic Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

d-sotalol reduces heart rate in vivo through a beta-adrenergic receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Clinical safety profile of sotalol in the treatment of arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Torsade de pointes due to quinidine: observations in 31 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Interobserver discordance in the classification of mechanisms of death in studies of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

The Cardiac Arrhythmia Suppression Trial: background, interim results and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

Controlled trial of sotalol for one year after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900006-X

10.1016/S0002-9149(98)00006-X

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

9555777

1 reference

24 March 2018